+62 813-8532-9115 info@scirepid.com

 
IJHM - International Journal of Health and Medicine - Vol. 2 Issue. 1 (2024)

Management Thalassemia in Indonesia : A Literature Review

Friska Kamila Nabilasefanty, Pradana Zaky Romadhon,



Abstract

Thalassemia is a disease classified in the group of hereditary hemolytic anemia caused by the failure of the formation of one of the four amino acid chains forming Hb, causing incomplete Hb formation. Thalassemia carriers account for 7% of the world's population.  At present, the cornerstone of treatment for ?-TM in Indonesia remains supportive, including blood transfusions and iron chelation therapy. With a comprehensive discussion about thalassemia in Indonesia, it is hoped that the diagnosis and treatment of thalassemia will be more optimal and effective in future research.







DOI :


Sitasi :

0

PISSN :

3047-7948

EISSN :

3047-793X

Date.Create Crossref:

13-Jan-2025

Date.Issue :

14-Dec-2024

Date.Publish :

14-Dec-2024

Date.PublishOnline :

14-Dec-2024



PDF File :

Resource :

Open

License :

https://creativecommons.org/licenses/by-sa/4.0